 | • レポートコード：GIR-107A14451 • 出版社/出版日：GlobalInfoResearch / 2021年7月23日 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、トラベクテジンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。トラベクテジンの種類別市場規模（注射剤、錠剤）、用途別市場規模（乳がん治療、前立腺がん治療、小児肉腫治療、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・トラベクテジンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Johnson and Johnson、Xeon Biopharmaceutical Limited、BrightGene Bio-Medical、Autran、Suzhou Borui Biology ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：注射剤、錠剤 ・用途別分析2016年-2026年：乳がん治療、前立腺がん治療、小児肉腫治療、その他 ・トラベクテジンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・トラベクテジンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・トラベクテジンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・トラベクテジンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・トラベクテジンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Trabectedin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Trabectedin size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Trabectedin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Trabectedin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Injection Product
Table Product
Market segment by Application, can be divided into
Breast Cancer Treatment
Prostate Cancer Treatment
Pediatric Sarcoma Treatment
Others
Market segment by players, this report covers
Johnson and Johnson
Xeon Biopharmaceutical Limited
BrightGene Bio-Medical
Autran
Suzhou Borui Biology
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Trabectedin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Trabectedin, with revenue, gross margin and global market share of Trabectedin from 2019 to 2021.
Chapter 3, the Trabectedin competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Trabectedin market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Trabectedin research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Trabectedin
1.2 Classification of Trabectedin by Type
1.2.1 Overview: Global Trabectedin Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Trabectedin Revenue Market Share by Type in 2020
1.2.3 Injection Product
1.2.4 Table Product
1.3 Global Trabectedin Market by Application
1.3.1 Overview: Global Trabectedin Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Breast Cancer Treatment
1.3.3 Prostate Cancer Treatment
1.3.4 Pediatric Sarcoma Treatment
1.3.5 Others
1.4 Global Trabectedin Market Size & Forecast
1.5 Global Trabectedin Market Size and Forecast by Region
1.5.1 Global Trabectedin Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Trabectedin Market Size by Region, (2016-2021)
1.5.3 North America Trabectedin Market Size and Prospect (2016-2026)
1.5.4 Europe Trabectedin Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Trabectedin Market Size and Prospect (2016-2026)
1.5.6 South America Trabectedin Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Trabectedin Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Trabectedin Market Drivers
1.6.2 Trabectedin Market Restraints
1.6.3 Trabectedin Trends Analysis
2 Company Profiles
2.1 Johnson and Johnson
2.1.1 Johnson and Johnson Details
2.1.2 Johnson and Johnson Major Business
2.1.3 Johnson and Johnson Trabectedin Product and Solutions
2.1.4 Johnson and Johnson Trabectedin Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Johnson and Johnson Recent Developments and Future Plans
2.2 Xeon Biopharmaceutical Limited
2.2.1 Xeon Biopharmaceutical Limited Details
2.2.2 Xeon Biopharmaceutical Limited Major Business
2.2.3 Xeon Biopharmaceutical Limited Trabectedin Product and Solutions
2.2.4 Xeon Biopharmaceutical Limited Trabectedin Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Xeon Biopharmaceutical Limited Recent Developments and Future Plans
2.3 BrightGene Bio-Medical
2.3.1 BrightGene Bio-Medical Details
2.3.2 BrightGene Bio-Medical Major Business
2.3.3 BrightGene Bio-Medical Trabectedin Product and Solutions
2.3.4 BrightGene Bio-Medical Trabectedin Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 BrightGene Bio-Medical Recent Developments and Future Plans
2.4 Autran
2.4.1 Autran Details
2.4.2 Autran Major Business
2.4.3 Autran Trabectedin Product and Solutions
2.4.4 Autran Trabectedin Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Autran Recent Developments and Future Plans
2.5 Suzhou Borui Biology
2.5.1 Suzhou Borui Biology Details
2.5.2 Suzhou Borui Biology Major Business
2.5.3 Suzhou Borui Biology Trabectedin Product and Solutions
2.5.4 Suzhou Borui Biology Trabectedin Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Suzhou Borui Biology Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Trabectedin Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Trabectedin Players Market Share
3.2.2 Top 10 Trabectedin Players Market Share
3.2.3 Market Competition Trend
3.3 Trabectedin Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Trabectedin Revenue and Market Share by Type (2016-2021)
4.2 Global Trabectedin Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Trabectedin Revenue Market Share by Application (2016-2021)
5.2 Trabectedin Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Trabectedin Revenue by Type (2016-2026)
6.2 North America Trabectedin Revenue by Application (2016-2026)
6.3 North America Trabectedin Market Size by Country
6.3.1 North America Trabectedin Revenue by Country (2016-2026)
6.3.2 United States Trabectedin Market Size and Forecast (2016-2026)
6.3.3 Canada Trabectedin Market Size and Forecast (2016-2026)
6.3.4 Mexico Trabectedin Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Trabectedin Revenue by Type (2016-2026)
7.2 Europe Trabectedin Revenue by Application (2016-2026)
7.3 Europe Trabectedin Market Size by Country
7.3.1 Europe Trabectedin Revenue by Country (2016-2026)
7.3.2 Germany Trabectedin Market Size and Forecast (2016-2026)
7.3.3 France Trabectedin Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Trabectedin Market Size and Forecast (2016-2026)
7.3.5 Russia Trabectedin Market Size and Forecast (2016-2026)
7.3.6 Italy Trabectedin Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Trabectedin Revenue by Type (2016-2026)
8.2 Asia-Pacific Trabectedin Revenue by Application (2016-2026)
8.3 Asia-Pacific Trabectedin Market Size by Region
8.3.1 Asia-Pacific Trabectedin Revenue by Region (2016-2026)
8.3.2 China Trabectedin Market Size and Forecast (2016-2026)
8.3.3 Japan Trabectedin Market Size and Forecast (2016-2026)
8.3.4 South Korea Trabectedin Market Size and Forecast (2016-2026)
8.3.5 India Trabectedin Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Trabectedin Market Size and Forecast (2016-2026)
8.3.7 Australia Trabectedin Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Trabectedin Revenue by Type (2016-2026)
9.2 South America Trabectedin Revenue by Application (2016-2026)
9.3 South America Trabectedin Market Size by Country
9.3.1 South America Trabectedin Revenue by Country (2016-2026)
9.3.2 Brazil Trabectedin Market Size and Forecast (2016-2026)
9.3.3 Argentina Trabectedin Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Trabectedin Revenue by Type (2016-2026)
10.2 Middle East & Africa Trabectedin Revenue by Application (2016-2026)
10.3 Middle East & Africa Trabectedin Market Size by Country
10.3.1 Middle East & Africa Trabectedin Revenue by Country (2016-2026)
10.3.2 Turkey Trabectedin Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Trabectedin Market Size and Forecast (2016-2026)
10.3.4 UAE Trabectedin Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Trabectedin Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Trabectedin Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Trabectedin Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Trabectedin Revenue (USD Million) by Region (2016-2021)
Table 5. Global Trabectedin Revenue Market Share by Region (2021-2026)
Table 6. Johnson and Johnson Corporate Information, Head Office, and Major Competitors
Table 7. Johnson and Johnson Major Business
Table 8. Johnson and Johnson Trabectedin Product and Solutions
Table 9. Johnson and Johnson Trabectedin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Xeon Biopharmaceutical Limited Corporate Information, Head Office, and Major Competitors
Table 11. Xeon Biopharmaceutical Limited Major Business
Table 12. Xeon Biopharmaceutical Limited Trabectedin Product and Solutions
Table 13. Xeon Biopharmaceutical Limited Trabectedin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. BrightGene Bio-Medical Corporate Information, Head Office, and Major Competitors
Table 15. BrightGene Bio-Medical Major Business
Table 16. BrightGene Bio-Medical Trabectedin Product and Solutions
Table 17. BrightGene Bio-Medical Trabectedin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Autran Corporate Information, Head Office, and Major Competitors
Table 19. Autran Major Business
Table 20. Autran Trabectedin Product and Solutions
Table 21. Autran Trabectedin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Suzhou Borui Biology Corporate Information, Head Office, and Major Competitors
Table 23. Suzhou Borui Biology Major Business
Table 24. Suzhou Borui Biology Trabectedin Product and Solutions
Table 25. Suzhou Borui Biology Trabectedin Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Trabectedin Revenue (USD Million) by Players (2019-2021)
Table 27. Global Trabectedin Revenue Share by Players (2019-2021)
Table 28. Breakdown of Trabectedin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Trabectedin Players Head Office, Products and Services Provided
Table 30. Trabectedin Mergers & Acquisitions in the Past Five Years
Table 31. Trabectedin New Entrants and Expansion Plans
Table 32. Global Trabectedin Revenue (USD Million) by Type (2016-2021)
Table 33. Global Trabectedin Revenue Share by Type (2016-2021)
Table 34. Global Trabectedin Revenue Forecast by Type (2021-2026)
Table 35. Global Trabectedin Revenue by Application (2016-2021)
Table 36. Global Trabectedin Revenue Forecast by Application (2021-2026)
Table 37. North America Trabectedin Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Trabectedin Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Trabectedin Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Trabectedin Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Trabectedin Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Trabectedin Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Trabectedin Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Trabectedin Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Trabectedin Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Trabectedin Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Trabectedin Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Trabectedin Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Trabectedin Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Trabectedin Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Trabectedin Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Trabectedin Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Trabectedin Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Trabectedin Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Trabectedin Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Trabectedin Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Trabectedin Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Trabectedin Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Trabectedin Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Trabectedin Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Trabectedin Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Trabectedin Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Trabectedin Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Trabectedin Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Trabectedin Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Trabectedin Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Trabectedin Picture
Figure 2. Global Trabectedin Revenue Market Share by Type in 2020
Figure 3. Injection Product
Figure 4. Table Product
Figure 5. Trabectedin Revenue Market Share by Application in 2020
Figure 6. Breast Cancer Treatment Picture
Figure 7. Prostate Cancer Treatment Picture
Figure 8. Pediatric Sarcoma Treatment Picture
Figure 9. Others Picture
Figure 10. Global Trabectedin Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Trabectedin Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Trabectedin Revenue Market Share by Region (2016-2026)
Figure 13. Global Trabectedin Revenue Market Share by Region in 2020
Figure 14. North America Trabectedin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Trabectedin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Trabectedin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Trabectedin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Trabectedin Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Trabectedin Market Drivers
Figure 20. Trabectedin Market Restraints
Figure 21. Trabectedin Market Trends
Figure 22. Johnson and Johnson Recent Developments and Future Plans
Figure 23. Xeon Biopharmaceutical Limited Recent Developments and Future Plans
Figure 24. BrightGene Bio-Medical Recent Developments and Future Plans
Figure 25. Autran Recent Developments and Future Plans
Figure 26. Suzhou Borui Biology Recent Developments and Future Plans
Figure 27. Global Trabectedin Revenue Share by Players in 2020
Figure 28. Trabectedin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 29. Global Top 3 Players Trabectedin Revenue Market Share in 2020
Figure 30. Global Top 10 Players Trabectedin Revenue Market Share in 2020
Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 32. Global Trabectedin Revenue Share by Type in 2020
Figure 33. Global Trabectedin Market Share Forecast by Type (2021-2026)
Figure 34. Global Trabectedin Revenue Share by Application in 2020
Figure 35. Global Trabectedin Market Share Forecast by Application (2021-2026)
Figure 36. North America Trabectedin Sales Market Share by Type (2016-2026)
Figure 37. North America Trabectedin Sales Market Share by Application (2016-2026)
Figure 38. North America Trabectedin Revenue Market Share by Country (2016-2026)
Figure 39. United States Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Trabectedin Sales Market Share by Type (2016-2026)
Figure 43. Europe Trabectedin Sales Market Share by Application (2016-2026)
Figure 44. Europe Trabectedin Revenue Market Share by Country (2016-2026)
Figure 45. Germany Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. France Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. United Kingdom Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Russia Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Italy Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Trabectedin Sales Market Share by Type (2016-2026)
Figure 51. Asia-Pacific Trabectedin Sales Market Share by Application (2016-2026)
Figure 52. Asia-Pacific Trabectedin Revenue Market Share by Region (2016-2026)
Figure 53. China Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Japan Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. South Korea Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. India Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Southeast Asia Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Australia Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South America Trabectedin Sales Market Share by Type (2016-2026)
Figure 60. South America Trabectedin Sales Market Share by Application (2016-2026)
Figure 61. South America Trabectedin Revenue Market Share by Country (2016-2026)
Figure 62. Brazil Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Argentina Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Middle East and Africa Trabectedin Sales Market Share by Type (2016-2026)
Figure 65. Middle East and Africa Trabectedin Sales Market Share by Application (2016-2026)
Figure 66. Middle East and Africa Trabectedin Revenue Market Share by Country (2016-2026)
Figure 67. Turkey Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Saudi Arabia Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. UAE Trabectedin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Methodology
Figure 71. Research Process and Data Source